Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1985 Nov;63:141–147. doi: 10.1289/ehp.8563141

Water content of aluminum, dialysis dementia, and osteomalacia.

M R Wills, J Savory
PMCID: PMC1568504  PMID: 3908086

Abstract

In the presence of normal renal function, a high concentration of aluminum in drinking water has been implicated as a factor in the etiology of a neurological syndrome in one specific geographical area. The role of aluminum as a toxic agent in other neurological disorders, where renal function is normal, is controversial. Aluminum is absorbed from the gastrointestinal tract and is normally excreted by the kidneys in the urine. In patients with chronic renal failure, aluminum appears to be of proven toxicological importance. In these patients the accumulation of aluminum in tissues causes an encephalopathy (dialysis encephalopathy or dialysis dementia), a specific form of metabolic bone disease (osteomalacic dialysis osteodystrophy), and an anemia and also plays an etiological role in some of the other complications associated with end-stage chronic renal disease. A failure in the normal renal excretory mechanism accounts for the tissue accumulation in chronic renal failure. The majority of chronic renal failure patients who develop aluminum toxicity are on long-term treatment with either hemo- or peritoneal dialysis; some patients develop toxicity who are only on treatment with aluminum-containing phosphate-binding agents. Aluminum in the dialysate appears to be the major source of the metal in chronic renal failure patients who develop aluminum toxicity. The aluminum content of the dialysate depends primarily on the content of the water with which it is prepared; there may be some contribution from the chemicals used in the concentrate which is added to the water. Some domestic tap-water supplies contain aluminum in high concentration, either naturally or because aluminum has been added as a flocculant in the purification process.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alfrey A. C. Dialysis encephalopathy syndrome. Annu Rev Med. 1978;29:93–98. doi: 10.1146/annurev.me.29.020178.000521. [DOI] [PubMed] [Google Scholar]
  2. Alfrey A. C., LeGendre G. R., Kaehny W. D. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med. 1976 Jan 22;294(4):184–188. doi: 10.1056/NEJM197601222940402. [DOI] [PubMed] [Google Scholar]
  3. Alfrey A. C., Mishell J. M., Burks J., Contiguglia S. R., Rudolph H., Lewin E., Holmes J. H. Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Intern Organs. 1972;18(0):257-61, 266-7. doi: 10.1097/00002480-197201000-00064. [DOI] [PubMed] [Google Scholar]
  4. Andreoli S. P., Bergstein J. M., Sherrard D. J. Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med. 1984 Apr 26;310(17):1079–1084. doi: 10.1056/NEJM198404263101704. [DOI] [PubMed] [Google Scholar]
  5. Berlyne G. M., Ben-Ari J., Pest D., Weinberger J., Stern M., Levine R., Gilmore G. R. Hyperaluminaemia from aluminum resins in renal failure. Lancet. 1970 Sep 5;2(7671):494–496. doi: 10.1016/s0140-6736(70)90113-3. [DOI] [PubMed] [Google Scholar]
  6. Berlyne G. M., Yagil R., Ari J. B., Weinberger G., Knopf E., Danovitch G. M. Aluminium toxicity in rats. Lancet. 1972 Mar 11;1(7750):564–568. doi: 10.1016/s0140-6736(72)90357-1. [DOI] [PubMed] [Google Scholar]
  7. Blomfield J., McPherson J., George C. R. Active uptake of copper and zinc during haemodialysis. Br Med J. 1969 Apr 19;2(5650):141–145. doi: 10.1136/bmj.2.5650.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Burks J. S., Alfrey A. C., Huddlestone J., Norenberg M. D., Lewin E. A fatal encephalopathy in chronic haemodialysis patients. Lancet. 1976 Apr 10;1(7963):764–768. doi: 10.1016/s0140-6736(76)91608-1. [DOI] [PubMed] [Google Scholar]
  9. CAMPBELL I. R., CASS J. S., CHOLAK J., KEHOE R. A. Aluminum in the environment of man; a review of its hygienic status. AMA Arch Ind Health. 1957 May;15(5):359–448. [PubMed] [Google Scholar]
  10. Clarkson E. M., Luck V. A., Hynson W. V., Bailey R. R., Eastwood J. B., Woodhead J. S., Clements V. R., O'Riordan J. L., De Wardener H. E. The effect of aluminium hydroxide on calcium, phosphorus and aluminium balances, the serum parathyroid hormone concentration and the aluminium content of bone in patients with chronic renal failure. Clin Sci. 1972 Oct;43(4):519–531. doi: 10.1042/cs0430519. [DOI] [PubMed] [Google Scholar]
  11. Cronan C. S., Schofield C. L. Aluminum leaching response to Acid precipitation: effects on high-elevation watersheds in the northeast. Science. 1979 Apr 20;204(4390):304–306. doi: 10.1126/science.204.4390.304. [DOI] [PubMed] [Google Scholar]
  12. Davison A. M., Walker G. S., Oli H., Lewins A. M. Water supply aluminium concentration, dialysis dementia, and effect of reverse-osmosis water treatment. Lancet. 1982 Oct 9;2(8302):785–787. doi: 10.1016/s0140-6736(82)92678-2. [DOI] [PubMed] [Google Scholar]
  13. Gacek E. M., Babb A. L., Uvelli D. A., Fry D. L., Scribner B. H. Dialysis dementia: the role of dialysate pH in altering the dialyzability of aluminum. Trans Am Soc Artif Intern Organs. 1979;25:409–415. [PubMed] [Google Scholar]
  14. Garruto R. M., Fukatsu R., Yanagihara R., Gajdusek D. C., Hook G., Fiori C. E. Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1875–1879. doi: 10.1073/pnas.81.6.1875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Griswold W. R., Reznik V., Mendoza S. A., Trauner D., Alfrey A. C. Accumulation of aluminum in a nondialyzed uremic child receiving aluminum hydroxide. Pediatrics. 1983 Jan;71(1):56–58. [PubMed] [Google Scholar]
  16. Kaehny W. D., Alfrey A. C., Holman R. E., Shorr W. J. Aluminum transfer during hemodialysis. Kidney Int. 1977 Nov;12(5):361–365. doi: 10.1038/ki.1977.123. [DOI] [PubMed] [Google Scholar]
  17. Kaye M. Oral aluminum toxicity in a non-dialyzed patient with renal failure. Clin Nephrol. 1983 Oct;20(4):208–211. [PubMed] [Google Scholar]
  18. King R. G., Sharp J. A., Boura A. L. The effects of Al3+, Cd2+ and Mn2+ on human erythrocyte choline transport. Biochem Pharmacol. 1983 Dec 1;32(23):3611–3617. doi: 10.1016/0006-2952(83)90312-x. [DOI] [PubMed] [Google Scholar]
  19. Kosik K. S., Bradley W. G., Good P. F., Rasool C. G., Selkoe D. J. Cholinergic function in lumbar aluminum myelopathy. J Neuropathol Exp Neurol. 1983 Jul;42(4):365–375. doi: 10.1097/00005072-198307000-00001. [DOI] [PubMed] [Google Scholar]
  20. Lai J. C., Blass J. P. Inhibition of brain glycolysis by aluminum. J Neurochem. 1984 Feb;42(2):438–446. doi: 10.1111/j.1471-4159.1984.tb02697.x. [DOI] [PubMed] [Google Scholar]
  21. Leeming R. J., Blair J. A. Dialysis dementia, aluminium, and tetrahydrobiopterin metabolism. Lancet. 1979 Mar 10;1(8115):556–556. doi: 10.1016/s0140-6736(79)90981-4. [DOI] [PubMed] [Google Scholar]
  22. Lieberherr M., Grosse B., Cournot-Witmer G., Thil C. L., Balsan S. In vitro effects of aluminum on bone phosphatases: a possible interaction with bPTH and vitamin D3 metabolites. Calcif Tissue Int. 1982 May;34(3):280–284. doi: 10.1007/BF02411251. [DOI] [PubMed] [Google Scholar]
  23. Marquis J. K. Aluminum neurotoxicity: an experimental perspective. Bull Environ Contam Toxicol. 1982 Jul;29(1):43–49. doi: 10.1007/BF01606087. [DOI] [PubMed] [Google Scholar]
  24. Mayor G. H., Sprague S. M., Sanchez T. V. Determinants of tissue aluminum concentration. Am J Kidney Dis. 1981 Nov;1(3):141–145. doi: 10.1016/s0272-6386(81)80019-4. [DOI] [PubMed] [Google Scholar]
  25. McKinney T. D., Basinger M., Dawson E., Jones M. M. Serum aluminum levels in dialysis dementia. Nephron. 1982;32(1):53–56. doi: 10.1159/000182802. [DOI] [PubMed] [Google Scholar]
  26. Parkinson I. S., Ward M. K., Feest T. G., Fawcett R. W., Kerr D. N. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet. 1979 Feb 24;1(8113):406–409. doi: 10.1016/s0140-6736(79)90883-3. [DOI] [PubMed] [Google Scholar]
  27. Parkinson I. S., Ward M. K., Kerr D. N. Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis. J Clin Pathol. 1981 Nov;34(11):1285–1294. doi: 10.1136/jcp.34.11.1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Parsons V., Davies C., Goode C., Ogg C., Siddiqui J. Aluminium in bone from patients with renal failure. Br Med J. 1971 Oct 30;4(5782):273–275. doi: 10.1136/bmj.4.5782.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Perl D. P., Brody A. R. Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science. 1980 Apr 18;208(4441):297–299. doi: 10.1126/science.7367858. [DOI] [PubMed] [Google Scholar]
  30. Perl D. P., Gajdusek D. C., Garruto R. M., Yanagihara R. T., Gibbs C. J. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science. 1982 Sep 10;217(4564):1053–1055. doi: 10.1126/science.7112111. [DOI] [PubMed] [Google Scholar]
  31. Platts M. M., Goode G. C., Hislop J. S. Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis. Br Med J. 1977 Sep 10;2(6088):657–660. doi: 10.1136/bmj.2.6088.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Savory J., Wills M. R. Dialysis fluids as a source of aluminum accumulation. Contrib Nephrol. 1984;38:12–23. doi: 10.1159/000408062. [DOI] [PubMed] [Google Scholar]
  33. Schreeder M. T., Favero M. S., Hughes J. R., Petersen N. J., Bennett P. H., Maynard J. E. Dialysis encephalopathy and aluminum exposure: an epidemiologic analysis. J Chronic Dis. 1983;36(8):581–593. doi: 10.1016/0021-9681(83)90146-7. [DOI] [PubMed] [Google Scholar]
  34. Shore D., Wyatt R. J. Aluminum and Alzheimer's disease. J Nerv Ment Dis. 1983 Sep;171(9):553–558. doi: 10.1097/00005053-198309000-00005. [DOI] [PubMed] [Google Scholar]
  35. Sideman S., Manor D. The dialysis dementia syndrome and aluminum intoxication. Nephron. 1982;31(1):1–10. doi: 10.1159/000182595. [DOI] [PubMed] [Google Scholar]
  36. Slanina P., Falkeborn Y., Frech W., Cedergren A. Aluminium concentrations in the brain and bone of rats fed citric acid, aluminium citrate or aluminium hydroxide. Food Chem Toxicol. 1984 May;22(5):391–397. doi: 10.1016/0278-6915(84)90369-7. [DOI] [PubMed] [Google Scholar]
  37. Sorenson J. R., Campbell I. R., Tepper L. B., Lingg R. D. Aluminum in the environment and human health. Environ Health Perspect. 1974 Aug;8:3–95. doi: 10.1289/ehp.7483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Thomas W. C., Meyer J. L. Aluminum-induced osteomalacia: an explanation. Am J Nephrol. 1984;4(3):201–203. doi: 10.1159/000166807. [DOI] [PubMed] [Google Scholar]
  39. Ward M. K., Feest T. G., Ellis H. A., Parkinson I. S., Kerr D. N. Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium. Lancet. 1978 Apr 22;1(8069):841–845. doi: 10.1016/s0140-6736(78)90191-5. [DOI] [PubMed] [Google Scholar]
  40. Wills M. R., Savory J. Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia. Lancet. 1983 Jul 2;2(8340):29–34. doi: 10.1016/s0140-6736(83)90014-4. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES